.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Dow
AstraZeneca
Teva
US Department of Justice
McKinsey
Healthtrust
Citi
Cantor Fitzgerald

Generated: November 20, 2017

DrugPatentWatch Database Preview

Histamine-1 Receptor Inhibitor Drug-Class List

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
ELESTAT
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC021565-001Oct 16, 2003ATRXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
EMADINE
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 1997RXYesYes► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090870-001Mar 14, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Somerset Theraps Llc
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090951-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090919-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC091626-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204055-001May 5, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC206046-001Jul 26, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Somerset Theraps Llc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC206306-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC078350-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Julphar
Merck
Federal Trade Commission
Boehringer Ingelheim
Medtronic
Cerilliant
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot